Back to Search
NAVTEJ BUTTAR, M.D.
M.D.
Gastroenterology Physician
NPI: 1568449247IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
40381(MN)
CMS Specialties
PrimaryGASTROENTEROLOGY
Education
OTHER
Class of 1989
Research & Publications (20)
Rodent endosonography to monitor esophageal cancer.
PMID 17827527·Int J Gastrointest Cancer·2006
7-preclinical
Key role of Krüppel-like factor proteins in pancreatic cancer and other gastrointestinal neoplasias.
PMID 16891881·Curr Opin Gastroenterol·2006
6-review
Mechanisms of disease: Carcinogenesis in Barrett's esophagus.
PMID 16265072·Nat Clin Pract Gastroenterol Hepatol·2004
6-review
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus.
PMID 11910360·Gastroenterology·2002
7-preclinical
The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
PMID 11904314·J Natl Cancer Inst·2002
8-other
Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus.
PMID 11726842·Gastrointest Endosc·2001
3-trial
Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.
PMID 11375945·Gastroenterology·2001
8-other
Pathogenesis of gastroesophageal reflux and Barrett esophagus.
PMID 11213315·Mayo Clin Proc·2001
6-review
The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors.
PMID 11040851·Mayo Clin Proc·2000
4-observational
Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus.
PMID 19524578·Gastroenterology·2009
4-observational
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
PMID 18413730·Cancer Res·2008
8-other
Photodynamic therapy for Barrett's esophagus: does light still have a role?
PMID 19065486·Endoscopy·2008
6-review
Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus.
PMID 18553366·Cancer·2008
3-trial
Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus.
PMID 18538141·Gastroenterology·2008
8-other
Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus.
PMID 17640326·Am J Gastroenterol·2007
8-other
COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma.
PMID 17604323·Gut·2007
7-preclinical
Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.
PMID 17570215·Gastroenterology·2007
7-preclinical
An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer.
PMID 17564704·Cancer Immunol Immunother·2007
8-other
Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma.
PMID 17545000·Clin Gastroenterol Hepatol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1568449247
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile